American Century Companies’s Cullinan Oncology CGEM Stock Holding History

American Century Companies's CGEM Position: Q2 2026 in Review

American Century Companies increased its Cullinan Oncology (CGEM) stake by 8.5% in Q2 2026, buying an estimated $181K and bringing the position to 156,317 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2091.

American Century Companies first reported a position in CGEM in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.34M in Q2 2023. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

• American Century Companies held 156,317 shares of Cullinan Oncology worth $2.85M as of Q2 2026.
• American Century Companies bought 12,210 Cullinan Oncology shares in Q2 2026, an estimated $181K.
• Cullinan Oncology made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2091 holding.
• American Century Companies first reported a position in Cullinan Oncology in Q3 2022 and has held it in 16 quarters since.
• American Century Companies's Cullinan Oncology position peaked at $3.34M in Q2 2023.
• 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.